Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging of Cholesterol Trafficking with [18F]FNP-59 in Healthy Subjects
NCT04532489Phase 1Recruiting
- Start
- Jan 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of FNP-59. Primary endpoint: Standardized Uptake Value at Day 0. Started Jan 2021; status: recruiting.
02
Drugs
FNP-59
Beyond the preview
Go deeper on NCT04532489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04532489.